Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J KEATING

Showing results (661-670 of 1,115) with videos related to

Pageof 112
Sort By:
Neoplasia (New York, N.Y.)|September 2, 2017
The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia CellsHima V Vangapandu, Mary L Ayres, Christopher A Bristow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Response to salvage therapy and survival after relapse in acute myelogenous leukemiaM J Keating, H Kantarjian, T L Smith, et al.
Heart Rhythm|August 19, 2014
Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakersMaday Gonzalez, Richard J Keating, Steven M Markowitz, et al.
Blood|February 16, 2010
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cellsInbal Hazan-Halevy, David Harris, Zhiming Liu, et al.
Neurogastroenterology and Motility|January 28, 2026
The Neuroepithelial Landscape of Enterochromaffin Cells Varies Across Gastrointestinal LocationLauren A Jones, Rosie A Coleman, Caitlin Allman, et al.
Leukemia|October 16, 2004
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabineJ S Carew, S T Nawrocki, R H Xu, et al.
The American Journal of Medicine|September 1, 1987
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patientsH M Kantarjian, M J Keating, M Talpaz, et al.
The American Journal of Medicine|September 1, 1986
Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaH M Kantarjian, E H Estey, W Plunkett, et al.
Blood Cancer Journal|September 3, 2016
ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)Y Jiang, H-C Chen, X Su, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Pageof 112

Showing results (661-670 of 1,115) with videos related to

Sort By:
Pageof 112
Neoplasia (New York, N.Y.)|September 2, 2017
The Stromal Microenvironment Modulates Mitochondrial Oxidative Phosphorylation in Chronic Lymphocytic Leukemia CellsHima V Vangapandu, Mary L Ayres, Christopher A Bristow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Response to salvage therapy and survival after relapse in acute myelogenous leukemiaM J Keating, H Kantarjian, T L Smith, et al.
Heart Rhythm|August 19, 2014
Newly detected atrial high rate episodes predict long-term mortality outcomes in patients with permanent pacemakersMaday Gonzalez, Richard J Keating, Steven M Markowitz, et al.
Blood|February 16, 2010
STAT3 is constitutively phosphorylated on serine 727 residues, binds DNA, and activates transcription in CLL cellsInbal Hazan-Halevy, David Harris, Zhiming Liu, et al.
Neurogastroenterology and Motility|January 28, 2026
The Neuroepithelial Landscape of Enterochromaffin Cells Varies Across Gastrointestinal LocationLauren A Jones, Rosie A Coleman, Caitlin Allman, et al.
Leukemia|October 16, 2004
Increased mitochondrial biogenesis in primary leukemia cells: the role of endogenous nitric oxide and impact on sensitivity to fludarabineJ S Carew, S T Nawrocki, R H Xu, et al.
The American Journal of Medicine|September 1, 1987
Chronic myelogenous leukemia in blast crisis. Analysis of 242 patientsH M Kantarjian, M J Keating, M Talpaz, et al.
The American Journal of Medicine|September 1, 1986
Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemiaH M Kantarjian, E H Estey, W Plunkett, et al.
Blood Cancer Journal|September 3, 2016
ATM function and its relationship with ATM gene mutations in chronic lymphocytic leukemia with the recurrent deletion (11q22.3-23.2)Y Jiang, H-C Chen, X Su, et al.
Blood|July 1, 1992
Response assessment in chronic lymphocytic leukemia after fludarabine plus prednisone: clinical, pathologic, immunophenotypic, and molecular analysisL E Robertson, Y O Huh, J J Butler, et al.
Pageof 112